Tag: Codman Neuro
Cerenovus launches in Europe
Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the European Society of Minimally Invasive Neurological Therapy (ESMINT) 9th Annual...
Cerenovus introduced at SNIS
Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July,...
Codman Neuro acquires Neuravi
Codman Neuro has announced the acquisition of Neuravi. This acquisition comes after the company’s recent acquisition of Pulsar Vascular, expanding its products for stroke...
Codman Neuro announces acquisition of Pulsar Vascular Inc
Codman Neuro has announced the acquisition of Pulsar Vascular Inc, a privately-held company with breakthrough platform technology for the neurovascular treatment of complex aneurysms. DePuy...
Codman Neuro agrees US distribution of InNeuroCo intermediate catheters
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has entered into an agreement with InNeuroCo for exclusive US and European distribution...
Codman Neuro gains exclusive rights to market and promote PulseRider in...
PulseRider is a minimally invasive device intended for use with embolic coils in the treatment of unruptured wide-neck intracranial aneurysms originating on or near a bifurcation.
